{"name":"Axion Bio, Inc","slug":"axion-bio-inc","ticker":"","exchange":"","domain":"","description":"Axion Bio, Inc is a biotechnology company focused on the development of innovative therapies. The company's lead candidate, AXN-2510, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"Unknown","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AXN-2510","genericName":"AXN-2510","slug":"axn-2510","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AXN-2510","genericName":"AXN-2510","slug":"axn-2510","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9UOWxPc2IzRVJyak9vWHBscUxldkdmNWtnZ053NzJCSURpWmpVdTlNVGtrdkVNdndiRHNTaUFNNWxjcHZkU0E3ZHZoekVTanRBeUR1QW43SGRYeEZxMzJfT0dOeUkwU3I2elJBYw?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Instil Bio, Inc. (TIL) - Stock Titan","headline":"If You Invested $1,000 in Instil Bio, Inc. (TIL)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQc0E0M18xMXVnOHI0bXVfb05OYnZMN3B2RjlwWHBUdjFlNWJXbWNjSjNNMjFyMnhrNlBnbkFFcTFDR3Z5MlIwZ0ZZXzE0bk9haWNSX09iNzhLRW0zdzlDTDJjRTFHSWlub01nUVI5ZmtJSFdzcTRWT0lsRUcyQV9IMWZqbWxBRG1kWGlBaHJFajZMeC1CRTBfLUxiWFhOYnJDUHVFNTM2UURaOVM2U0ZsMFB2MkpHR0tuZlZ2ejc5S2tMU3A1NGcxUHBLdw?oc=5","date":"2026-01-14","type":"deal","source":"Caixin Global","summary":"Chinese Drugmakers Strike Record $136 Billion in Cross-Border Licensing Deals - Caixin Global","headline":"Chinese Drugmakers Strike Record $136 Billion in Cross-Border Licensing Deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOU3A0UVRucE1wOXF6cUVSMEI3ejdBVDRWZmRkVUJKaWt1WnlWaDQwaWkydS0yRzdCdGFGaTY3d2I1UHJCUDN3WWJncFR1MEdQMDBOOGRyYm4teWJta1BRSXB1QUotVFBNaE9NV2UxaHVsSnU2TXpOU3drWmJlR0dPWXBQcFF5U1pZYmZyMjF2V3h2MFZrUWM1NVJpQzB3cjB5WUJsN1NEbzEzRnh2RGF6dFZGc1JvYnRuU1E?oc=5","date":"2026-01-06","type":"pipeline","source":"Stock Titan","summary":"Instil Bio and ImmuneOnco unwind AXN-2510 pact as development stops - Stock Titan","headline":"Instil Bio and ImmuneOnco unwind AXN-2510 pact as development stops","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNRUtQUlV0YTNaXzBiZjVWQ3NnZFMwZDh1VU9GVV9NSFVQU3JPbjVRNzNHZjB1YWpFTTNnLURiLUZfaGowN1Rqd2E5XzNaSFZFdko1WDgxdVJkN0hyWWYzXzJnZDBzMWpmQmcxQ0cxdlI1YVdtRldzXzNmeW1EZ0ZLRUZralRTS1pUbUw5Um5lS1dBOC1xcXhnby1jUUlVMXU5VE1QMGtHR3NUdw?oc=5","date":"2024-12-09","type":"pipeline","source":"BioWorld News","summary":"Boryung invests $10M in Intuitive Machines for outer space R&D - BioWorld News","headline":"Boryung invests $10M in Intuitive Machines for outer space R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPQVFNTUJqc3VqY2lEUjhnZ2l4bFRPY1pnOHRJbGFPbFdIc0s1MFdqOGl6U2F1NzM1V0xINE1UUjFlRnUtaVptdjVjMThXaVpzMk5rbTJlUGF1S1RBNU1RYlNoaUdWODMyR09TdXE3ODZodEhOcmlTdXAyODhlSWRFZlNBa0JGWnNoYkN5REt5bjJmZnU4UWNlV3ZxYXA3LVJWTVVENTZuZjBudTNTSl9Rc2Jwc0VWaHN6WHc?oc=5","date":"2024-08-07","type":"pipeline","source":"Stock Titan","summary":"Axion BioSystems Continues Agreement Giving Corning® Exclusive Rights to Distribute Award-Winning Cell Counting Device - Stock Titan","headline":"Axion BioSystems Continues Agreement Giving Corning® Exclusive Rights to Distribute Award-Winning Cell Counting Device","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8xRktSWjZVb3IyQk5TZkJIdk9uZXUyalo2OHVEV1dVdXR6YndUWThlcnpyaVpOSzNOcnR0V3ZiYWJXOWFjcFJPNjBMZVI0UUpGbFgycEFmYjBIdWZ3TGlQWF95SXhoZFFoNWo5QnRB?oc=5","date":"2023-05-02","type":"pipeline","source":"PharmTech.com","summary":"Frontrunner in Organ-on-a-Chip - PharmTech.com","headline":"Frontrunner in Organ-on-a-Chip","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxObnVlTnVEOU1USC0yZlBSNHM5dWJobXhKN092anJWTjdTOHBQMjE0UFBURWNzUkV0UHBLZTdXMjJ2VUJTRFhaaXdqd2o0T0NRU1pJY1doWkItOE51dVQ0MEhDakhFWkdqQnNodEtDQUdESEZGMG1RaHVGVk5kSGlEcjhvUzdINzNGeGhKM1BhbFkweVV6cWcyT3h3emZpbDZPc3BLcUQtbVBxYnZHeW84Y3IzUmVUQmUxSUdJMVI5SzhpRkRNLWpoSFRCTnJkWUl5RFdrZWowMVQ?oc=5","date":"2023-01-30","type":"pipeline","source":"Business Wire","summary":"Axion BioSystems Launches New High-Throughput Live-Cell Imaging Platform, Omni Pro 12 - Business Wire","headline":"Axion BioSystems Launches New High-Throughput Live-Cell Imaging Platform, Omni Pro 12","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPT2JoYlRDN1BTZWVUTWEtM21qcjR5VF9qTjBfRXVJdE9MbG1SLU1kUUtncVdjQkhQTklqVFVEQS1hRHdESjZlYi1UbFpNbUh1NFpVLUJobXZBRW5ONUU1OUJHZ1NhWjVqWlViYlhlMUNKcElUSWN5OXZVdUd2VUkwT2tlNmlmNXNQaVF0RGl4dDVxc0RleTBCV2xKbHcyOUFMb203QUplU1FKNjc5UVFJUEJDdUsxb0RNakI2elZWbWNUYVlMdEd5cVBMQ2xUdw?oc=5","date":"2022-03-21","type":"deal","source":"Business Wire","summary":"Axion BioSystems Acquires Live-Cell Imaging Innovator CytoSMART Technologies - Business Wire","headline":"Axion BioSystems Acquires Live-Cell Imaging Innovator CytoSMART Technologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNMk0wMXRzZ0E3VGNlUzZ4WDNLWFNUSTZ2eE1uTkxKRllETXZwb3VqRlprdHhyOThhVU9zYXFnX0VTUW1oTXlmU1NZb0I4Z0xUTFdUSEc3X0I0d2JtZWxsQXItUEdWQkJHSXBsUG1QV0h6bmtTWjRoc01pamRnaEZYWjNOVGFSWmVBVmpMSjZraHNYZWM5c2RIWnJ3d2hOajF1b3lUNkVfWjRqMXJLbzlR?oc=5","date":"2016-05-16","type":"pipeline","source":"PR Newswire","summary":"Axion BioSystems completes successful equity financing - PR Newswire","headline":"Axion BioSystems completes successful equity financing","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}